Skip to main content

Support WBUR

FDA Expedites Treatment Of Seriously Ill COVID-19 Patients With Experimental Plasma

The U.S. Food and Drug Administration announced that it will make it easier for an experimental plasma to be tried on patients with COVID-19. (AP)
The U.S. Food and Drug Administration announced that it will make it easier for an experimental plasma to be tried on patients with COVID-19. (AP)

Support WBUR

Support WBUR

Listen Live